The motorcycle-riding, guitar-playing Collins announced Tuesday he will step down by the end of the year from his job as chief of the research agency, having served more than a dozen years under three presidents.
The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
At least four healthcare executives have either resigned, been fired or taken on a lesser role since the first of the year — and the head of NIH may be out soon, too.
Also, Abbott tries to get out of $5.8B Alere deal, FDA issues rules for "compassionate use" and Apple poaches star doc from Lucile Packard Children's Hospital.
President Obama will try to budget $215 million for his new precision medicine program, with plans to build a huge database that contains the genetic information, medical records and other information of more than a million Americans. It’ll largely involve aggregating already-existing patient data from volunteers, with the intent to help doctors and researchers understand […]
Two recent stories in the New York Times caught my attention because they seem to represent the opposite sides of the same coin. Or as we like to call it, the American healthcare system. In a moving piece in the Sunday Times Magazine, Katy Butler describes how a pacemaker kept her elderly father alive, but […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Psychiatrist Charles Nemeroff, formerly of Emory University, now at the University of Miami, remains the poster child for conflicts of interest in medicine run amok. The National Institutes of Health continues to dig a deeper hole in its dealings with its erstwhile grantee. For those not following the latest turns in the Nemeroff saga, the […]
The National Institutes of Health has approved the first 13 lines of embryonic stem cells for use by federal researchers, ushering in a new era of research that is both promising and controversial.
The U.S. Senate unanimously confirmed Dr. Francis Collins -- a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project -- as director of the National Institutes of Health. "Dr. Collins is one of our generation's great scientific leaders," said Health and Human Services Secretary Kathleen Sebelius.